Assessment of Five Serum Marker Assays in Patients with Advanced Breast Cancer Treated with Medroxyprogesterone Acetate

By Murray A.   Clinton O.   Earl H.   Price M.   Moore A.  

European Journal of Cancer, Vol. 31, Iss. 10, 1995-09 ,pp. : 1605-1610

Elsevier

Access to resources Recommend Favorite

Predictive Factors for Response to Chemotherapy in Advanced Breast Cancer

By Sjöström Johanna  

Acta Oncologica, Vol. 41, Iss. 4, 2002-06 ,pp. : 334-345

Informa Healthcare

Access to resources Recommend Favorite

Apoptosis inhibition mediated by medroxyprogesterone acetate treatment of breast cancer cell lines

By Ory K.  

Breast Cancer Research and Treatment, Vol. 68, Iss. 3, 2001-08 ,pp. : 187-198

Springer Publishing Company

Access to resources Recommend Favorite

A Randomised Phase III Cross-over Study of Tamoxifen Versus Megestrol Acetate in Advanced and Recurrent Breast Cancer

By Stuart N.S.A.   Warwick J.   Blackledge G.R.P.   Spooner D.   Keen C.   Taylor A.R.   Tyrell C.   Webster D.J.T.   Earl H.  

European Journal of Cancer, Vol. 32, Iss. 11, 1996-10 ,pp. : 1888-1892

Elsevier

Access to resources Recommend Favorite

Predictive value of tumour cell proliferation in locally advanced breast cancer treated with neoadjuvant chemotherapy

By Aas T.   Geisler S.   Eide G.E.   Haugen D.F.   Varhaug J.E.   Bassoe A.M.   Thorsen T.   Berntsen H.   Borresen-Dale A.-L.   Akslen L.A.   Lonning P.E.  

European Journal of Cancer, Vol. 39, Iss. 4, 2003-03 ,pp. : 438-446

Elsevier

Access to resources Recommend Favorite